200 related articles for article (PubMed ID: 27325396)
1. Dopamine D3 receptor Ser9Gly variant is associated with impulse control disorders in Parkinson's disease patients.
Krishnamoorthy S; Rajan R; Banerjee M; Kumar H; Sarma G; Krishnan S; Sarma S; Kishore A
Parkinsonism Relat Disord; 2016 Sep; 30():13-7. PubMed ID: 27325396
[TBL] [Abstract][Full Text] [Related]
2. Behavioral addictions in early-onset Parkinson disease are associated with DRD3 variants.
Castro-Martínez XH; García-Ruiz PJ; Martínez-García C; Martínez-Castrillo JC; Vela L; Mata M; Martínez-Torres I; Feliz-Feliz C; Palau F; Hoenicka J
Parkinsonism Relat Disord; 2018 Apr; 49():100-103. PubMed ID: 29361389
[TBL] [Abstract][Full Text] [Related]
3. Association of DRD3 and GRIN2B with impulse control and related behaviors in Parkinson's disease.
Lee JY; Lee EK; Park SS; Lim JY; Kim HJ; Kim JS; Jeon BS
Mov Disord; 2009 Sep; 24(12):1803-10. PubMed ID: 19562769
[TBL] [Abstract][Full Text] [Related]
4. Association of the DRD2 CA
Xu S; Liu J; Yang X; Qian Y; Xiao Q
J Neurol Sci; 2017 Jan; 372():433-438. PubMed ID: 27817855
[TBL] [Abstract][Full Text] [Related]
5. Association of the DRD2 and DRD3 polymorphisms with response to pramipexole in Parkinson's disease patients.
Liu YZ; Tang BS; Yan XX; Liu J; Ouyang DS; Nie LN; Fan L; Li Z; Ji W; Hu DL; Wang D; Zhou HH
Eur J Clin Pharmacol; 2009 Jul; 65(7):679-83. PubMed ID: 19396436
[TBL] [Abstract][Full Text] [Related]
6. Clinical-genetic model predicts incident impulse control disorders in Parkinson's disease.
Kraemmer J; Smith K; Weintraub D; Guillemot V; Nalls MA; Cormier-Dequaire F; Moszer I; Brice A; Singleton AB; Corvol JC
J Neurol Neurosurg Psychiatry; 2016 Oct; 87(10):1106-11. PubMed ID: 27076492
[TBL] [Abstract][Full Text] [Related]
7. DRD and GRIN2B polymorphisms and their association with the development of impulse control behaviour among Malaysian Parkinson's disease patients.
Zainal Abidin S; Tan EL; Chan SC; Jaafar A; Lee AX; Abd Hamid MH; Abdul Murad NA; Pakarul Razy NF; Azmin S; Ahmad Annuar A; Lim SY; Cheah PS; Ling KH; Mohamed Ibrahim N
BMC Neurol; 2015 Apr; 15():59. PubMed ID: 25896831
[TBL] [Abstract][Full Text] [Related]
8. Dopamine Receptor D3 rs6280 is Associated with Aberrant Decision-Making in Parkinson's Disease.
Rajan R; Krishnan S; Sarma G; Sarma SP; Kishore A
Mov Disord Clin Pract; 2018; 5(4):413-416. PubMed ID: 30363458
[TBL] [Abstract][Full Text] [Related]
9. Association of dopamine receptor D3 polymorphism with Levodopa-induced Dyskinesia: A study on Parkinson's disease patients from India.
Sarkar S; Biswas A; Ansari S; Choudhury S; Banerjee R; Chatterjee S; Dey S; Kumar H
Neurosci Lett; 2024 Mar; 825():137706. PubMed ID: 38431040
[TBL] [Abstract][Full Text] [Related]
10. Behavioural and trait changes in parkinsonian patients with impulse control disorder after switching from dopamine agonist to levodopa therapy: results of REIN-PD trial.
Lee JY; Jeon B; Koh SB; Yoon WT; Lee HW; Kwon OD; Kim JW; Kim JM; Ma HI; Kim HT; Baik JS; Cho J;
J Neurol Neurosurg Psychiatry; 2019 Jan; 90(1):30-37. PubMed ID: 30361296
[TBL] [Abstract][Full Text] [Related]
11. Influence of DRD1 and DRD3 Polymorphisms in the Occurrence of Motor Effects in Patients with Sporadic Parkinson's Disease.
Dos Santos EUD; Duarte EBC; Miranda LMR; Asano AGC; Asano NMJ; Maia MMD; de Souza PRE
Neuromolecular Med; 2019 Sep; 21(3):295-302. PubMed ID: 31119645
[TBL] [Abstract][Full Text] [Related]
12. Association of DRD2 and DRD3 polymorphisms with Parkinson's disease in a multiethnic consortium.
McGuire V; Van Den Eeden SK; Tanner CM; Kamel F; Umbach DM; Marder K; Mayeux R; Ritz B; Ross GW; Petrovitch H; Topol B; Popat RA; Costello S; Manthripragada AD; Southwick A; Myers RM; Nelson LM
J Neurol Sci; 2011 Aug; 307(1-2):22-9. PubMed ID: 21663922
[TBL] [Abstract][Full Text] [Related]
13. Suggestive association between OPRM1 and impulse control disorders in Parkinson's disease.
Cormier-Dequaire F; Bekadar S; Anheim M; Lebbah S; Pelissolo A; Krack P; Lacomblez L; Lhommée E; Castrioto A; Azulay JP; Defebvre L; Kreisler A; Durif F; Marques-Raquel A; Brefel-Courbon C; Grabli D; Roze E; Llorca PM; Ory-Magne F; Benatru I; Ansquer S; Maltête D; Tir M; Krystkowiak P; Tranchant C; Lagha-Boukbiza O; Lebrun-Vignes B; Mangone G; Vidailhet M; Charbonnier-Beaupel F; Rascol O; Lesage S; Brice A; Tezenas du Montcel S; Corvol JC;
Mov Disord; 2018 Dec; 33(12):1878-1886. PubMed ID: 30444952
[TBL] [Abstract][Full Text] [Related]
14. Tremor in Parkinson's disease is not associated with the DRD3 Ser9Gly polymorphism.
Paus S; Gadow F; Kaut O; Knapp M; Klein C; Klockgether T; Wüllner U
Parkinsonism Relat Disord; 2010 Jul; 16(6):381-3. PubMed ID: 20434388
[TBL] [Abstract][Full Text] [Related]
15. Dopamine D3 receptor Ser9Gly variant is associated with impulse control disorders in Parkinson's disease patients.
Bhattacharjee S; Talbot JG; Vijayashankar P
Parkinsonism Relat Disord; 2017 Jan; 34():69-70. PubMed ID: 27802909
[No Abstract] [Full Text] [Related]
16. DRD3 gene rs6280 polymorphism may be associated with alcohol dependence overall and with Lesch type I alcohol dependence in Koreans.
Kang SG; Lee BH; Lee JS; Chai YG; Ko KP; Lee HJ; Han DM; Ji H; Jang GH; Shin HE
Neuropsychobiology; 2014; 69(3):140-6. PubMed ID: 24776816
[TBL] [Abstract][Full Text] [Related]
17. Association of Parkinson disease age of onset with DRD2, DRD3 and GRIN2B polymorphisms.
Hassan A; Heckman MG; Ahlskog JE; Wszolek ZK; Serie DJ; Uitti RJ; van Gerpen JA; Okun MS; Rayaprolu S; Ross OA
Parkinsonism Relat Disord; 2016 Jan; 22():102-5. PubMed ID: 26627941
[TBL] [Abstract][Full Text] [Related]
18. Association between DRD2 and DRD3 gene polymorphisms and gastrointestinal symptoms induced by levodopa therapy in Parkinson's disease.
Rieck M; Schumacher-Schuh AF; Altmann V; Callegari-Jacques SM; Rieder CRM; Hutz MH
Pharmacogenomics J; 2018 Jan; 18(1):196-200. PubMed ID: 27779245
[TBL] [Abstract][Full Text] [Related]
19. Impulse control disorder in patients with Parkinson's disease under dopamine agonist therapy: a multicentre study.
Garcia-Ruiz PJ; Martinez Castrillo JC; Alonso-Canovas A; Herranz Barcenas A; Vela L; Sanchez Alonso P; Mata M; Olmedilla Gonzalez N; Mahillo Fernandez I
J Neurol Neurosurg Psychiatry; 2014 Aug; 85(8):840-4. PubMed ID: 24434037
[TBL] [Abstract][Full Text] [Related]
20. DRD3 Predicts Cognitive Impairment and Anxiety in Parkinson's Disease: Susceptibility and Protective Effects.
Gonçalves A; Mendes A; Damásio J; Vila-Chã N; Boleixa D; Leal B; Cavaco S
J Parkinsons Dis; 2024; 14(2):313-324. PubMed ID: 38363619
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
